{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:54:26Z","timestamp":1777794866206,"version":"3.51.4"},"reference-count":78,"publisher":"Elsevier","isbn-type":[{"value":"9780443430862","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.acr.2026.01.011","type":"book-chapter","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:43:34Z","timestamp":1770295414000},"page":"355-379","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical and clinical trials in nanotech skin cancer treatment"],"prefix":"10.1016","author":[{"given":"Jeet Kumar","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6665-3432","authenticated-orcid":false,"given":"Satyajit","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuhin","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradip","family":"Jana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swadesh Kumar","family":"Pattanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8130-1822","authenticated-orcid":false,"given":"Pranav Kumar","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.acr.2026.01.011_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042165","article-title":"Nanotechnology as a promising method in the treatment of skin cancer","volume":"25","author":"Adamus-Grabicka","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.acr.2026.01.011_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28155905","article-title":"Exploring nanocarriers as treatment modalities for skin cancer","volume":"28","author":"Adnan","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/bs.acr.2026.01.011_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101856","article-title":"The combinational application of photodynamic therapy and nanotechnology in skin cancer treatment: A review","volume":"77","author":"Adnane","year":"2022","journal-title":"Tissue & Cell"},{"key":"10.1016\/bs.acr.2026.01.011_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125203","article-title":"Recent advances in lipid-based nanocarriers for advanced skin cancer therapy","volume":"670","author":"Ali","year":"2025","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/bs.acr.2026.01.011_bib5","article-title":"Barriers and facilitators to sun protection: A proposal for a skin cancer public health prevention campaign in Atlantic Canada","author":"Alli","year":"2025","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"issue":"3","key":"10.1016\/bs.acr.2026.01.011_bib6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/pharmaceutics14030600","article-title":"Development, therapeutic evaluation and theranostic applications of cubosomes on cancers: An updated review","volume":"14","author":"Almoshari","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.011_bib7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/s12672-025-02664-3","article-title":"Nanotechnology in oncology: Advances in biosynthesis, drug delivery, and theranostics","volume":"16","author":"Ammar","year":"2025","journal-title":"Discover Oncology"},{"key":"10.1016\/bs.acr.2026.01.011_bib8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.semcancer.2022.04.005","article-title":"Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives","volume":"86","author":"Ansari","year":"2022","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/bs.acr.2026.01.011_bib9","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.2147\/IJN.S250001","article-title":"A review on the biodistribution, pharmacokinetics and toxicity of bismuth-based nanomaterials","volume":"15","author":"Badrigilan","year":"2020","journal-title":"International Journal of Nanomedicine"},{"issue":"12","key":"10.1016\/bs.acr.2026.01.011_bib10","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2174\/0113892010302313240610111842","article-title":"Nanoemulsions in skin cancer therapy: A promising frontier","volume":"26","author":"Basu","year":"2024","journal-title":"Current Pharmaceutical Biotechnology"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.011_bib11","first-page":"27","article-title":"Modeling melanoma in vitro and in vivo","volume":"2","author":"Beaumont","year":"2013","journal-title":"Healthcare (Basel, Switzerland)"},{"key":"10.1016\/bs.acr.2026.01.011_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116649","article-title":"Nanotechnology-empowered strategies in treatment of skin cancer","author":"Chandra","year":"2023","journal-title":"Environmental Research"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.011_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2024047670","article-title":"Elevating therapeutic penetration: Innovations in drug delivery for enhanced permeation and skin cancer management","volume":"42","author":"Chaudhary","year":"2025","journal-title":"Critical Reviews in Therapeutic Drug Carrier Systems"},{"key":"10.1016\/bs.acr.2026.01.011_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: Overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Molecular Cancer"},{"key":"10.1016\/bs.acr.2026.01.011_bib15","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s11426-018-9397-5","article-title":"Precise nanomedicine for intelligent therapy of cancer","volume":"61","author":"Chen","year":"2018","journal-title":"Science China Chemistry"},{"key":"10.1016\/bs.acr.2026.01.011_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16070960","article-title":"Development and evaluation of docetaxel-loaded nanostructured lipid carriers for skin cancer therapy","volume":"16","author":"Coco\u015f","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.acr.2026.01.011_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115197","article-title":"Beyond the adverse effects of the systemic route: Exploiting nanocarriers for the topical treatment of skin cancers","author":"Da Silva Gomes","year":"2024","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"Pt A","key":"10.1016\/bs.acr.2026.01.011_bib18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?","volume":"244","author":"Danhier","year":"2016","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"key":"10.1016\/bs.acr.2026.01.011_bib19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/17425247.2024.2392799","article-title":"Exploring the therapeutic modalities of targeted treatment approach for skin carcinoma: cutting-edge strategies and key insights","volume":"21","author":"Desai","year":"2024","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/bs.acr.2026.01.011_bib20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/17425247.2023.2221026","article-title":"Nanocarrier functionalization strategies for targeted drug delivery in skin cancer therapy: Current progress and upcoming challenges","volume":"20","author":"Di Filippo","year":"2023","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"8","key":"10.1016\/bs.acr.2026.01.011_bib21","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.3390\/curroncol30080516","article-title":"Nanoparticle-based treatment approaches for skin cancer: A systematic review","volume":"30","author":"Diaz","year":"2023","journal-title":"Current Oncology (Toronto, Ont.)"},{"issue":"3","key":"10.1016\/bs.acr.2026.01.011_bib22","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","article-title":"Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles","volume":"172","author":"Ernsting","year":"2013","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"key":"10.1016\/bs.acr.2026.01.011_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.acr.2026.01.011_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/metabo15030201","article-title":"Nanomedicines targeting metabolic pathways in the tumor microenvironment: Future perspectives and the role of AI","volume":"15","author":"Fan","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/bs.acr.2026.01.011_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043493","article-title":"Enhancing skin cancer immunotheranostics and precision medicine through functionalized nanomodulators and nanosensors: Recent development and prospects","volume":"24","author":"Farhana","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.011_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/jpm7040012","article-title":"Personalized nanomedicine: A revolution at the nanoscale","volume":"7","author":"Fornaguera","year":"2017","journal-title":"Journal of Personalized Medicine"},{"key":"10.1016\/bs.acr.2026.01.011_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/NSA.S495377","article-title":"3D computational modeling of Fe3O4@Au nanoparticles in hyperthermia treatment of skin cancer","volume":"18","author":"Gas","year":"2025","journal-title":"Nanotechnology, Science and Applications"},{"issue":"1-2","key":"10.1016\/bs.acr.2026.01.011_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10555-012-9410-8","article-title":"Reconstructing skin cancers using animal models","volume":"32","author":"Gober","year":"2013","journal-title":"Cancer Metastasis Reviews"},{"key":"10.1016\/bs.acr.2026.01.011_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29898","article-title":"Lipid-based nanoparticles as a promising treatment for the skin cancer","volume":"10","author":"Golestani","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/bs.acr.2026.01.011_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01854-3","article-title":"Skin cancer: Understanding the journey of transformation from conventional to advanced treatment approaches","volume":"22","author":"Hasan","year":"2023","journal-title":"Molecular Cancer"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.011_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00403-025-03817-8","article-title":"Recent advances in improved efficacies of gold nano-formulations in treatment of skin cancer: A systematic review","volume":"317","author":"Heydari","year":"2025","journal-title":"Archives of Dermatological Research"},{"key":"10.1016\/bs.acr.2026.01.011_bib32","article-title":"CAR products from novel sources: A new avenue for the breakthrough in cancer immunotherapy","volume":"15","author":"Huang","year":"2024","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.acr.2026.01.011_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jtemb.2018.04.033","article-title":"Selectivity and sensitivity of molybdenum oxide-polycaprolactone nanofiber composites on skin cancer: Preliminary in-vitro and in-vivo implications","volume":"49","author":"Janani","year":"2018","journal-title":"Journal of Trace Elements in Medicine and Biology: Organ of the Society for Minerals and Trace Elements"},{"key":"10.1016\/bs.acr.2026.01.011_bib34","article-title":"Nanomedicines and nanomaterials for cancer therapy: Progress, challenge and perspectives","author":"Jing","year":"2022","journal-title":"Chemical Engineering Journal"},{"key":"10.1016\/bs.acr.2026.01.011_bib35","doi-asserted-by":"crossref","DOI":"10.2174\/1389201023666220404113242","article-title":"Recent advances of nanotechnology in the treatment of skin cancer","author":"Kanugo","year":"2022","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/bs.acr.2026.01.011_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2021.08.003","article-title":"Advanced nanomedicine approaches applied for treatment of skin carcinoma","author":"Kaur","year":"2021","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"15","key":"10.1016\/bs.acr.2026.01.011_bib37","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.1039\/D3NR06333J","article-title":"Macrophage-modulating nanomedicine for cancer immunotherapy","volume":"16","author":"Khan","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/bs.acr.2026.01.011_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jare.2021.06.014","article-title":"Skin cancer biology and barriers to treatment: Recent applications of polymeric micro\/nanostructures","volume":"36","author":"Khan","year":"2021","journal-title":"Journal of Advanced Research"},{"key":"10.1016\/bs.acr.2026.01.011_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-023-01463-z","article-title":"Advances of medical nanorobots for future cancer treatments","volume":"16","author":"Kong","year":"2023","journal-title":"Journal of Hematology & Oncology"},{"key":"10.1016\/bs.acr.2026.01.011_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2020.05.011","article-title":"Nanoparticles for topical drug delivery: Potential for skin cancer","author":"Krishnan","year":"2020","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.acr.2026.01.011_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.nxnano.2024.100129","article-title":"Nanomedicine: How nanomaterials are transforming drug delivery, bio-imaging, and diagnosis","volume":"7","author":"Kurul","year":"2025","journal-title":"Next Nanotechnology"},{"key":"10.1016\/bs.acr.2026.01.011_bib42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41417-021-00299-4","article-title":"Nanomedicine-based cancer immunotherapy: Recent trends and future perspectives","volume":"28","author":"Lakshmanan","year":"2021","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/bs.acr.2026.01.011_bib43","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.2147\/IJN.S506000","article-title":"Illuminating hope for tumors: The progress of light-activated nanomaterials in skin cancer","volume":"20","author":"Lei","year":"2025","journal-title":"International Journal of Nanomedicine"},{"issue":"8","key":"10.1016\/bs.acr.2026.01.011_bib44","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1021\/acs.molpharmaceut.4c00276","article-title":"Advancing mRNA therapeutics: The role and future of nanoparticle delivery systems","volume":"21","author":"Li","year":"2024","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.acr.2026.01.011_bib45","article-title":"Concurrent photothermal therapy and photodynamic therapy for cutaneous squamous cell carcinoma by gold nanoclusters under a single NIR laser irradiation","author":"Liu","year":"2019","journal-title":"Journal of Materials Chemistry. B"},{"key":"10.1016\/bs.acr.2026.01.011_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091817","article-title":"How to treat melanoma? The current status of innovative nanotechnological strategies and the role of minimally invasive approaches like PTT and PDT","volume":"14","author":"Lopes","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.acr.2026.01.011_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/23523689241311783","article-title":"Innovations in skin cancer treatment: The role of nanotechnology and cellular biotechnology","author":"Mamadapur","year":"2025","journal-title":"Journal of Cellular Biotechnology"},{"key":"10.1016\/bs.acr.2026.01.011_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1514399","article-title":"Advances and prospects of precision nanomedicine in personalized tumor theranostics","volume":"12","author":"Mao","year":"2024","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.011_bib49","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/acsptsci.4c00679","article-title":"Drug repurposing and nanotechnology for topical skin cancer treatment: Redirecting toward targeted and synergistic antitumor effects","volume":"8","author":"Martins","year":"2025","journal-title":"ACS Pharmacology & Translational Science"},{"key":"10.1016\/bs.acr.2026.01.011_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2346941","article-title":"Applications of metallic nanoparticles in the skin cancer treatment","volume":"2022","author":"Marzi","year":"2022","journal-title":"BioMed Research International"},{"key":"10.1016\/bs.acr.2026.01.011_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17030296","article-title":"Advances in materials science for precision melanoma therapy: Nanotechnology-enhanced drug delivery systems","volume":"17","author":"Moni","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.011_bib52","article-title":"Editorial: New target for skin cancer","volume":"34","author":"Nakamura","year":"2025","journal-title":"Experimental Dermatology"},{"key":"10.1016\/bs.acr.2026.01.011_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s43094-024-00686-2","article-title":"Novel paradigm of therapeutic intervention for skin cancer: Challenges and opportunities","author":"Nasim","year":"2024","journal-title":"Future Journal of Pharmaceutical Sciences"},{"key":"10.1016\/bs.acr.2026.01.011_bib54","article-title":"Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer","author":"Padya","year":"2020","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.acr.2026.01.011_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2022.10.023","article-title":"Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis","author":"Pei","year":"2022","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"11","key":"10.1016\/bs.acr.2026.01.011_bib56","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.3390\/ijms25115842","article-title":"Nanoformulations in pharmaceutical and biomedical applications: Green perspectives","volume":"25","author":"Petrovic","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.acr.2026.01.011_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcab.2024.103333","article-title":"Evaluation of cytotoxicity of silver nanoparticles on human skin melanoma SK- MEL-3 cell line: In vitro model","volume":"60","author":"Thakur","year":"2024","journal-title":"Biocatalysis and Agricultural Biotechnology"},{"key":"10.1016\/bs.acr.2026.01.011_bib58","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-13-2541-0_9","article-title":"Future prospective of nanotechnology in skin cancer therapeutics","author":"Ray","year":"2019","journal-title":"Skin Aging & Cancer"},{"key":"10.1016\/bs.acr.2026.01.011_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29092073","article-title":"Therapeutic applications of nanomedicine: recent developments and future perspectives","volume":"29","author":"Rehan","year":"2024","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/bs.acr.2026.01.011_bib60","article-title":"A comprehensive update on nanoparticle in targeting of skin cancer therapy: Recent updates, challenges, and future perspectives","author":"Sahoo","year":"2024","journal-title":"Research Journal of Pharmacy and Technology"},{"issue":"16 suppl.","key":"10.1016\/bs.acr.2026.01.011_bib61","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.2025.43.16_suppl.1653","article-title":"Teledermatology-dermoscopy: Expanding access to skin cancer screening to reduce healthcare disparities","volume":"43","author":"Santellano","year":"2025","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.acr.2026.01.011_bib62","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bioactmat.2023.10.017","article-title":"Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives","volume":"32","author":"Shen","year":"2023","journal-title":"Bioactive Materials"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.011_bib63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.11.001","article-title":"Skin cancer and new treatment perspectives: A review","volume":"357","author":"Sim\u014fes","year":"2015","journal-title":"Cancer Letters"},{"key":"10.1016\/bs.acr.2026.01.011_bib64","article-title":"Innovations in Skin Cancer Nanotechnology: A Comprehensive Review","author":"Singh","year":"2024","journal-title":"Pharmaceutical nanotechnology"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.011_bib65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10637-006-9002-y","article-title":"A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma","volume":"25","author":"Smylie","year":"2007","journal-title":"Investigational New Drugs"},{"key":"10.1016\/bs.acr.2026.01.011_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.30708","article-title":"Recent developments in nanomedicine for melanoma treatment","volume":"141","author":"Tang","year":"2017","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.acr.2026.01.011_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104394","article-title":"Nanomedicine: A pragmatic approach for tackling melanoma skin cancer","volume":"83","author":"Prajapat","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.011_bib68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00008390-200304000-00015","article-title":"Phase II study of pegylated liposomal doxorubicin in patients with metastatic malignant melanoma failing standard chemotherapy treatment","volume":"13","author":"Vorobiof","year":"2003","journal-title":"Melanoma Research"},{"key":"10.1016\/bs.acr.2026.01.011_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01889-y","article-title":"Current advance of nanotechnology in diagnosis and treatment for malignant tumors","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.011_bib70","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/21691401.2021.1918134","article-title":"A polymer-lipid membrane artificial cell nanocarrier containing enzyme-oxygen biotherapeutic inhibits the growth of B16F10 melanoma in 3D culture and in a mouse model","volume":"49","author":"Wang","year":"2021","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"key":"10.1016\/bs.acr.2026.01.011_bib71","article-title":"Cancer nanomedicine: Emerging strategies and therapeutic potentials","volume":"28","author":"Xu","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/bs.acr.2026.01.011_bib72","article-title":"Nanodelivery approaches of phytoactives for skin cancers: Current and future perspectives","author":"Yapar","year":"2024","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/bs.acr.2026.01.011_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2018.05.008","article-title":"Perspectives on the past, present, and future of cancer nanomedicine","volume":"130","author":"Youn","year":"2018","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.acr.2026.01.011_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01708-4","article-title":"Advancements in nanoparticle-based treatment approaches for skin cancer therapy","volume":"22","author":"Zeng","year":"2023","journal-title":"Molecular Cancer"},{"issue":"7","key":"10.1016\/bs.acr.2026.01.011_bib75","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1021\/acsabm.0c00269","article-title":"In vitro and in vivo toxicity and biodistribution of paclitaxel-loaded cubosomes as a drug delivery nanocarrier: A case study using an A431 skin cancer xenograft model","volume":"3","author":"Zhai","year":"2020","journal-title":"ACS Applied Bio Materials"},{"key":"10.1016\/bs.acr.2026.01.011_bib76","article-title":"Functionalization of nanomaterials for skin cancer theranostics","volume":"10","author":"Zhang","year":"2022","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"10.1016\/bs.acr.2026.01.011_bib77","article-title":"Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects","author":"Zhang","year":"2022","journal-title":"Med"},{"key":"10.1016\/bs.acr.2026.01.011_bib78","article-title":"Advances in mechanisms and challenges in clinical translation of synergistic nanomaterial-based therapies for melanoma","volume":"13","author":"Zhang","year":"2025","journal-title":"Frontiers in Cell and Developmental Biology"}],"container-title":["Advances in Cancer Research","Innovative Nanotechnology: Transforming Skin Cancer Diagnosis and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X26000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X26000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:15:06Z","timestamp":1777493706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X26000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443430862"],"references-count":78,"URL":"https:\/\/doi.org\/10.1016\/bs.acr.2026.01.011","relation":{},"ISSN":["0065-230X"],"issn-type":[{"value":"0065-230X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}